The role of base excision repair in the sensitivity and resistance to temozolomide-mediated cell death

Cancer Research

Volumn 65, Issue 14, 2005, Pages 6394-6400

  Trivedi, Ram N ^a   Almeida, Karen H ^a   Fornsaglio, Jamie L ^a   Schamus, Sandra ^a   Sobol, Robert W ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ALKYLADENINE DNA GLYCOSYLASE; ALKYLATING AGENT; DNA DIRECTED DNA POLYMERASE BETA; DNA GLYCOSYLTRANSFERASE; DNA POLYMERASE IOTA; DNA POLYMERASE LAMBDA; HISTONE H2A; HISTONE H2AX; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER RESISTANCE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG SENSITIVITY; ENZYME PHOSPHORYLATION; EXCISION REPAIR; GENE OVEREXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA INTERFERENCE; WILD TYPE;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CELL DEATH; CELL LINE, TRANSFORMED; DACARBAZINE; DNA GLYCOSYLASES; DNA POLYMERASE BETA; DNA REPAIR; DRUG RESISTANCE, NEOPLASM; HISTONES; MICE; PHOSPHORYLATION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 22244448679     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0715     Document Type: Article

References (57)

1. Eton O, Legha SS, Moon TR, et al. Prognostic factors for survival of patients treated systemically for disseminated melanoma. J Clin Oncol 1998;16:1103-11.
2. Grossman SA, Batara JF. Current management of gliohlastoma multiforme. Semin Ontol 2004;31:635-44.
3. Rehin A, Hoang-Xuan K, Carpentier AF, Delattre JY. Primary brain tumours in adults. Lancet 2003;361:323-31.
4. Dinnes J, Cave C, Huang S, Milne R. A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant glioma. Br J Cancer 2002;86:501-5.
5. Gaya A, Rees J, Greenstein A, Stebbing J. The use of temozolomide in recurrent malignant gliomas. Cancer Treat Rev 2002;28:115-20.
6. 6-(4-bromothenyl)guanine on different temozolomide schedules in a human melanoma xenograft model. Int J Cancer 2002;100:615-7.
7. Eggermont AMM, Kirkwood JM, Re-evaluating the role of decarbazine in metastatic melanoma: what have we learned in 30 years? Eur J Cancer 2004;40:1825-36.
8. Middleton MR, Grob JJ, Aaronson N, et al. Randomized phase 111 study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma. J Clin Oncol 2000;18:158-66.
9. Ebert BL, Niemierko E, Shaffer K, Salgia R. Use of temozolomide with other cytotoxic chemotherapy in the treatment of patients with recurrent brain metastases from lung cancer. Oncologist 2003;8:69-75.
10. Christodoulou C, Bafaloukos D, Linardou H, et al. Temozolomide (TMZ) combined with cisplatin (CDDP) in patients with brain metastases from solid tumors: a Hellenic Cooperative Oncology Group (HeCOG) Phase II study. J Neurooncol 2005;71:61-5.
11. Chahlavi A, Kanner A, Peereboom D, Staugaitis SM, Elson P, Barnett G. Impact of chromosome 1p status in response of oligodendroglioma to temozolomide: preliminary results. J Neurooncol 2003;61:267-73.
12. Tentori L, Graziani G. Pharmacological strategies to increase the antitumor activity of methylating agents. Curr Med Chem 2002;9:1285-301.
13. Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science 2001;291:1284-9.
14. 6-benzylguanine-mediated enhancement of chemotherapy. Mol Cancer Ther 2002;1:943-8.
15. Barvaux VA, Ranson M, Brown R, McElhinney RS, McMurry TB, Margison GP. Dual repair modulation reverses Temozolomide resistance in vitro. Mol Cancer Ther 2004;3:123-7.
16. 6-benzylguanine. J Clin Pharmacol 2003;43:881-93.
17. 6-alkylguanine-DNA alkyltrunsferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chlorocthyl)-1-nitrosourea or temozolomide. Clin Cancer Res 2001;7:421-8.
18. 6-methylguanine-DNA methyltransferase in resistance of human brain tumor cell lines to the clinically relevant methylating agents temozolomide and streptozotocin. Clin Cancer Bes 1996;2:735-41.
19. 6-methylguanine-DNA methyltransferase to monofunotional alkylating-agent resistance in human brain tumor-derived cell lines. Mol Carcinog 1995;13:70-80.
20. 6- methylguanine-DNA methyltransferase to resistance to 1,3-(2-chtoroethyl)-1- nitrosourea in human brain tumor-derived cell lines. Mol Carcinog 1995;13:81-8.
21. Bocangel DB, Finkelstein S, Schold SC, Bhakat KK, Mitra S, Kokkinakis DM. Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res 2002;8:2725-34.
22. Sobol RW, Wilson SM. Mammalian DNA β-polymerase in hase excision repair of alkylation damage. Prog Nucleic Acid Res Mol Biol 2001;68:57-74.
23. Liu L, Gerson SL. Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway. Curr Opin Investig Drugs 2004;5:623-7.
24. Tentori L, Leonetti C, Scarsella M, et al. Systemic administration of GP1 15427, a novel poly(ADP-ribose) polymcrase-1 inhibitor, increases the antitumor activity of temozolomide against intracranial melanoma, glioma, lymphoma. Clin Cancer Res 2003;9:5370-9.
25. Bobola MS, Emond MJ, Blank A, et al. Apurinic endonuclease activity in adult gliomas and time to tumor progression after alkylating agent-based chemotherapy and after radiotherapy. Clin Cancer Res 2004;10:7875-83.
26. Undahl T, Wood RD. Quality control by DNA repair. Science 1999;286:1897-905.
27. Wilson SH, Sobol RW, Beard WA, Horton JK. Prasad R, Vande Berg BJ. DNA polymerase β and mammalian base excision repair. Cold Spring Harb Symp Quant Biol 2001;65:143-55.
28. Sobol RW, Horton JK, Kuhn R, et al. Requirement of mammalian DNA polymerase-β in base-excision repair. Nature 1996;379:183-6.
29. Sobol RW, Prasad R, Evenski A, et al. The lyase activity of the DNA repair protein β-polymerase protects from DNA-damage-induced cytotoxicity. Nature 2000;405:807-10.
30. Sobol RW, Kartalou M, Almeida KH, et al. Base excision repair intermediates induce p53-independent cytotoxic and genotoxic responses. J Biol Chem 2003;278:39951-9.
31. Sobol RW, Watson DE, Nakamura J, et al. Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci U S A 2002;99:6860-5.
32. Prasad R, Bebenek K, Hou E, et al. Localization of the deoxyrihose phosphate lyase active site in human UNA polymerase L by controlled proleolysis. J Biol Chem 2003;278:29649-54.
33. Bebenek K, Tissier A, Frank EG, et al. 5′-Deoxyribose phosphate lyase activity of human DNA polymerase ι in vitro. Science 2001;291:2156-9.
34. Garcia-Diaz M, Bebenek K, Kunkel TA, Blanco L. Identification of an intrinsic 5′-deoxyribose-5-phosphate lyase activity in human DNA polymerase λ: a possible role in base excision repair. J Biol Chem 2001;276:34659-63.
35. Rinne M, Caldwell D, Kelley MR. Transient adenoviral N-methylpurine DNA glycosylase overexpression imparts chemotherapeutic sensitivity to human breast cancer cells. Mol Cancer Ther 2004;3:955-67.
36. Miao F, Bouziane M, Dammann R, et al. 3-Methyladenine-DNA glycosylase (MPG protein) interacts with human RAD23 proteins. J Biol Chem 2000;275:28433-8.
37. McDonald JP, Frank EG, Plosky BS, et al. 129-Derived strains of mice are deficient in DNA polymerase L and have normal immunoglobulin hypermutation. J Exp Med 2003;198:635-43.
38. Berridge MV, Tan AS. Characterization of the cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT): subcellular localization, substrate dependence, and involvement of mitochondrial electron transport in MTT reduction. Arch Biochem Biophys 1993;303:474-82.
39. Sambrook J, Russell D. Molecular cloning: a laboratory manual. 3rd ed. New York: Cold Spring Harbor Laboratory Press; 2000.
40. Wilson SH. Mammalian base excision repair and DNA polymerase β. Mutat Res 1998;407:203-15.
41. Roth RB, Samson LD. 3-Methyladenine DNA glycosylase-deficient. Aag null mice display unexpected bone marrow alkylation resistance. Cancer Res 2002;62:656-60.
42. Engelward BP, Dreslin A, Christensen J, Huszar D, Kurahara C, Samson L. Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J 1996;15:945-52.
43. Haracska L, Prakash L, Prakash S. A mechanism for the exclusion of low-fidelity human Y-family DNA polymerases from base excision repair. Genes Dev 2003;17:2777-85.
44. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003;421:499-506.
45. Brown EJ, Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 2003;17:615-28.
46. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003;3:155-68.
47. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998;273:5858-68.
48. Ward IM, Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J Biol Chem 2001;276:47759-62.
49. Paull TT, Rogakou EP, Yamazaki V, Kirchgessner CU, Gellert M, Bonner WM. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr Biol 2000;10:886-95.
50. Chen HT, Bhandoola A, Difilippantonio MJ, et al. Response to RAG-mediated VDJ cleavage by NBS1 and γ-H2AX Science 2000;290:1962-5.
51. Rappoid I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J Cell Biol 2001;153:613-20.
52. Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant: in the cellular response to DNA double-strand breaks. J Cell Biol 2000;151:1381-90.
53. Dianov GL, Timchenko TV, Sinitsina OI. Kuzminov AV, Medvedev OA, Salganik RI. Repair of uracil residues closely spaced on the opposite strands of plasmid DNA results in double-strand break and deletion formation. Mol Gen Genet 1991;225:448-52.
54. Georgakilas AG, Bennett PV, Wilson DM III, Sutherland BM. Processing of bistranded abasic DNA clusters in γ-irradiated human hematopoietic cells. Nucleic Acids Res 2004;32:5609-20.
55. Malyarchuk S, Harrison L. DNA repair of clustered uracils in HeLa cells. J Mol Biol 2005;345:731-43.
56. Michel B, Flores MJ, Viguera E, Grompone G, Seigneur M, Bidnenko V, Rescue of arrested replication forks by homologous recombination. Proc Natl Acad Sci USA 2001;98:8181-8.
57. Michel B, Grompone G, Flores MJ, Bidnenko V. Multiple pathways process stalled replication forks. Proc Natl Acad Sci U S A 2004;101:12783-8.